Executive Management

Dr. Todd M. Fruchterman is President and Chief Executive Officer at Butterfly Network. As both a physician and a leader in medical technology, he has dedicated his career to promoting health and wellness through innovation. He joined the company in 2021, and will lead Butterfly as it enters the public market, remaining focused on the company’s core mission of enabling universal access to superior medical imaging by making high quality ultrasound affordable, easy-to-use, globally accessible and intelligently connected.

Dr. Fruchterman spent nearly ten years of his career at 3M Company (“3M”) where he held multiple roles, most recently as the President and General Manager of Medical Solutions at 3M, the largest division in the company, where he delivered transformational acquisitions and achieved global above-market, profitable growth. In his 23-year career, Dr. Fruchterman also held leadership positions at Kinetic Concepts, Inc., and Response Genetics, Inc., holding the positions of President, Chief Executive Officer, and Chief Operating Officer. He also has held various positions at Johnson & Johnson, leading worldwide biosurgical R&D for the Ethicon division; Schering-Plough. Most recently, he was Group President, Reliability Solutions at Flex.

Dr. Fruchterman’s broad-based experience spans the clinical, scientific, regulatory and business arenas. In industry he has focused on creating value in businesses with a passion for creative problem solving, innovation and excellence in execution, and has successfully commercialized and scaled disruptive technologies throughout his career,

Dr. Fruchterman holds 11 patents, has served on the board of directors of AdvaMed, and in 2019, was a core participant in the U.S. Department of HHS Deputy Secretary’s Innovation and Investment Summit. He is also a business advisor at Spindletop Capital, LLC and has served on the Leonard Davis Institute of Health Economics Executive Advisory Board, the Executive Committee of BioMed SA of San Antonio, the Board of Directors for LifeScience Alley and the Board of Directors of the Texas Life Science Center.

He received his Bachelor of Arts in Biological Basis of Behavior and Medical Doctorate degrees from the University of Pennsylvania, and his Ph.D. in Physiology and Biophysics at the University of Louisville, Kentucky.

Stephanie is the Chief Financial Officer at Butterfly Network. Prior to Butterfly, Stephanie was at Amazon leading global finance and analytics teams in domains including marketing, cloud computing infrastructure, customer service, delivery experience and hardware development.

Before joining Amazon, Stephanie held various financial roles at UGI Corp. and was a buy-side analyst with responsibility for fixed income investments in the power and energy sectors at Delaware Investments.

Stephanie holds a Master’s in Business Administration from Columbia Business School and a Bachelor of Arts from Yale University. She is also a CFA® charterholder.

Dr. John Martin is the Chief Medical Officer of Butterfly Network, a transformational medical device company that is democratizing medical imaging across the globe.

Dr. Martin completed a residency in general surgery and vascular surgery at Parkland Memorial Hospital in Dallas Texas. He is board certified in vascular surgery and a Fellow of the American College of Surgeons. He served in the United States Air Force for 7 years first as a corpsman and then after completing medical school and training he returned as a Surgeon.

He has held multiple positions throughout his career including Chief of Vascular Surgery and Director of Heart and Vascular Services at Anne Arundel Medical Center, President of Cardiology Associates, and Vice President of Physician Operations for MedStar Medical Group.

He is the founder and President of the Heart Health Foundation and the award-winning Dare to CARE Program. He is the author of multiple peer reviewed papers and book chapters, holds several patents and developed clinical software used across the country. An often-requested speaker, his most recent events include Wall Street Journal Live in Hong Kong and TedMed.

Mary Miller recently joined Butterfly Network, Inc. as its General Counsel. Mary has over 20 years of corporate legal experience. Prior to joining Butterfly Network, Mary served as the Chief Risk Officer and General Counsel of Columbia Care Inc., one of the largest vertically integrated medical marijuana operators in the United States, where she oversaw all legal, regulatory and compliance aspects of the organization, including helping to take the company public on the Canadian NEO exchange. Prior to joining Columbia Care, Mary was a member of Outside GC where she leveraged her business experience to provide startup, growth and established companies with proactive legal and risk management solutions, frequently serving as outside general counsel. Prior to Outside GC, Mary was the Founder and CEO of mosaicHUB, a digital media startup, which she sold to Purch Media in June of 2016. Prior to mosaicHUB, Mary spent over two years at the venture capital firm General Catalyst as General Counsel where she helped manage venture and growth investments. From 2007 to 2010, Mary was Vice President, Associate General Counsel and Corporate Secretary at Fidelity where she worked on a variety of corporate matters, including financings, strategic ventures and governance matters. Prior to Fidelity, Mary spent over seven years at Ropes & Gray where she had a general corporate practice with a focus on transactional work. Mary was named one of Boston Business Journal’s 2012 40 Under 40 and Mass High Tech’s 2013 Women to Watch. She received her J.D. from Boston College Law School, and B.A. from Boston College.

Stacey Pugh is the Chief Commercial Officer at Butterfly Network. As a leader in Medical Technology, she has more than 15 years of experience in medical device research, development and commercialization. Stacey joined Butterfly in 2021 and will lead the company in the planning, organization, and implementation of all sales and marketing activities.

Prior to Butterfly, Stacey was President of Medtronic’s Neurovascular Operating Unit, where she provided overall global strategic leadership, guided marketing and business development and was responsible for revenue growth. Prior to this role, Stacey was Vice President and General Manager of Neurovascular & Cerebral Spinal Fluid (CSF) businesses and was responsible for leading the company’s European, Middle Eastern and African (EMEA) business programs and developing trade strategies to support the global revenue and market share growth of Medtronic Neurovascular products.

In addition, Stacey held various leadership roles in Covidien’s Neurovascular division as Vice President of Global Medical Affairs where she provided strategic direction for all medical affairs activities and executed strategic market access plans.

As a registered nurse, Stacey spent the early years of her career in research, critical care and trauma nursing, and nursing education.

Darius is Chief Strategy Officer and Chief Business Development Officer at Butterfly Network (MedTech Unicorn), where he helps lead the company's fundraising, global health, commercial and strategic efforts. In 2018, and while a student at HBS, Darius raised $250 million dollars for Butterfly Network - the largest medical imaging raise in history.

Prior to coming to HBS, Darius was Head of Trading at Birch Grove Capital, a Global Cross-Asset Hedge Fund which manages over $1BN. In this capacity he was responsible for all trading across Credit, Equities, Convertibles, Bank Debt and Commodities as well as helping the CIO in risk and portfolio management.

Prior to Birch Grove, Darius built the Cross Asset Special Situations Desk at Morgan Stanley, where he was amongst the firm’s youngest hires. In this role, he was responsible for sourcing and structuring over $1BN in banking transactions and acted as the Firm’s specialist on Argentina during the default proceedings.

Darius holds a MBA from Harvard Business School and a B.S from Duke University, where he studied Neuroscience and Psychology, and worked for Dan Ariely, one of the world’s foremost Behavioral Economists. He speaks five languages, holds three passports and has lived and worked in New York, London, Buenos Aires and São Paulo.

Dr. Stoica is the Chief Technology Officer at Butterfly Network. In this role, he leads the company’s technology and product development operations. Prior to Butterfly Network, Dr. Stoica was the Chief Technology Officer for BioTelemetry, a leading remote cardiac monitoring company serving over 1 million patients a year.

At BioTelemetry Dr Stoica was responsible for hardware and software product development, product management, enterprise, and product information technology, as well as product manufacturing and distribution. In 2021 BioTelemetry was acquired by Philips.

Prior to BioTelemetry, Dr. Stoica held various leadership positions at IQVIA, with the last position as Senior Vice President, Systems Development. In that role he led the development of the company’s Data Cloud Platform. The Data Cloud supported the largest data brokerage business in the world, operated one of the top 20 private data clouds, it had over 120,000 data suppliers, and it managed more than 1 million data streams in over 100 countries.

Dr. Stoica’s other appointments include information technology positions in the health IT industry as well as research and teaching positions in academia. Dr. Stoica holds a Ph.D. in Computer Science and Engineering from the University of South Carolina.

Tim is a C-Suite Business Executive with over 20 years of business and HR leadership experience. During his career, he has worked in all facets and functions of HR focused on: Transformational HR and Business Strategy, Change Leadership, Leadership and Team Effectiveness, Diversity and Inclusivity Culture building, and Talent and Capability development. He has worked across numerous business segments and has lived abroad as an Expatriate with a number of global experiences.

Tim served as Executive Vice President and Chief Human Resources Officer since January 2017 for WellCare (acquired by Centene). In that role, he led the integrated HR function that was responsible for creating and driving the overarching talent and culture strategy that enabled WellCare’s enterprise-wide priorities, while being the confidant and coach to the CEO and C-suite executive team. Tim worked with the CEO to revamp several cultural aspects including fostering an inclusive environment and building out recognized diversity programs with the Chief Diversity Officer. He also upgraded many of the HR practices utilizing data and measures tied to business results. In his role, he was direct liaison to Compensation Committee and Board of Directors on all things around talent and pay.

Prior to WellCare, Tim was the head of human resources, corporate enterprise functions for Johnson & Johnson where he led overall HR and talent strategy and HR model transformation. During his 16 years with the company, he has held multiple, senior HR positions with increasing leadership that included global, in-country roles, change leadership and transformation, business partnership, talent management, and total rewards.

Tim holds a Bachelor’s degree from Seton Hall University and a masters degree in human resources management from Rutgers University. He also is a graduate of the Wharton School’s Executive Development Program for general management.